Health
Baricitinib treatment linked to reduced mortality in COVID-19 patients – EurekAlert
The rheumatoid arthritis drug baricitinib can block viral entry and reduce mortality in patients with moderate to severe COVID-19, according to translational research…
IMAGE: Volker M. Lauschke, associate professor
Department of Physiology and Pharmacology, Karolinska Institutet.
view more
Credit: Jannis Politidis
The rheumatoid arthritis drug baricitinib can block viral entry and reduce mortality in patients with moderate to severe COVID-19, according to translational research by an international team coordinated by researchers from Karolinska Institutet in Sweden. The findings, published in the journal Science Advances, support the continuation of ongoing…
Continue Reading
